Carl Icahn shares common ground with the FTC, which argued that Illumina’s acquisition of cancer test developer Grail would stifle competition and innovation.
A fight has broken out between veteran activist Carl Icahn and biotech company Illumina as the investor nominates three candidates to the board.
More than 200,000 military service members and veterans are suing 3M claiming its Combat Arms earplugs failed to protect them.
Activist investor Nelson Peltz wants a seat on Disney’s board, and a proxy fight may be simmering.
Some cybersecurity experts say CAPTCHA asking you to spot traffic lights is useless in the fight against bots, but the Google-owned technology is improving.
On the same day that Bob Iger returned to Disney, there was also news that Trian Fund Management snapped up a stake in the entertainment giant.
Inflationary pressures and a post-lockdown reset look poised to benefit traditional gyms and threaten connected at-home fitness equipment like Peloton.
The U.N.’s flagship annual climate summit, known as COP27, has encountered several problems in its opening days.
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}
){kind=link}